Synapse - Howard Scher

Search Within

Howard Scher

Results (137)

Microsatellite instability, tumor mutational burden, and response to immune checkpoint blockade in patients with prostate cancer

Journal Article

Lenis, A. T.; Ravichandran, V.; Brown, S.; Alam, S. M.; Katims, A.; Truong, H.; Reisz, P. A.; Vasselman, S.; Nweji, B.; Autio, K. A.; more...
Clinical Cancer Research (2024)

Fulltext@MSK | Save

Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy

Journal Article

Walmsley, C. S.; Jonsson, P.; Cheng, M. L.; McBride, S.; Kaeser, C.; Vargas, H. A.; Laudone, V.; Taylor, B. S.; Kappagantula, R.; Baez, P.; more...
npj Precision Oncology (2024)

Fulltext@MSK | Save

Gene-based confirmatory germline testing following tumor-only sequencing of prostate cancer

Journal Article

Truong, H.; Breen, K.; Nandakumar, S.; Sjoberg, D. D.; Kemel, Y.; Mehta, N.; Lenis, A. T.; Reisz, P. A.; Carruthers, J.; Benfante, N.; more...
European Urology (2023)

Fulltext@MSK | Save

Biochemical response (PSA0) and testosterone (T) recovery in Metacure, a multi-arm multi-modality (MM) therapy (tx) for very high risk localized (HRL) and low volume metastatic (LVM) prostatic adenocarcinoma

Meeting Abstract

Teo, M. Y.; McBride, S.; Gopalan, A.; Benoliel, H.; Eastham, J. A.; Goh, A.; Szmulewitz, R.; Morgans, A. K.; Bubley, G.; Gupta, S.; more...
Annals of Oncology (2021)

Fulltext@MSK | Save

PSA-targeted alpha-, beta-, and positron-emitting immunotheranostics in murine prostate cancer models and nonhuman primates

Journal Article

Veach, D. R.; Storey, C. M.; Lückerath, K.; Braun, K.; von Bodman, C.; Lamminmäki, U.; Kalidindi, T.; Strand, S. E.; Strand, J.; Altai, M.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

Changes in Ki-67 and cleaved caspase-3 (CC3) with short term androgen deprivation therapy (ADT) prior to prostatectomy as part of a trial in intermediate and high-risk prostate cancer (PC)

Meeting Abstract

Vargas Pivato de Almeida, D.; Chen, Y. B.; Autio, K. A.; Carver, B. S.; Slovin, S. F.; Danila, D. C.; Scher, H. I.; Touijer, K. A.; Rathkopf, D. E.
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Identification of the cells of origin and tumor heterogeneity in neuroendocrine prostate cancer (NEPC) by single-cell analysis

Meeting Abstract

Zhao, J. L.; Zaidi, S.; Chan, J.; Wadosky, K.; Karthaus, W.; Choi, D.; Agudelo Rivera, A.; Gopalan, A.; Rathkopf, D.; Carver, B.; more...
Cancer Research (2020)

Fulltext@MSK | Save

Comparison of magnetic resonance imaging-stratified clinical pathways and systematic transrectal ultrasound-guided biopsy pathway for the detection of clinically significant prostate cancer: A systematic review and meta-analysis of randomized controlled trials

Review

Woo, S.; Suh, C. H.; Eastham, J. A.; Zelefsky, M. J.; Morris, M. J.; Abida, W.; Scher, H. I.; Sidlow, R.; Becker, A. S.; Wibmer, A. G.; more...
European Urology Oncology (2019)

Fulltext@MSK | Save

Metacure: Multi-arm multimodality therapy for very high risk localized and low volume metastatic prostatic adenocarcinoma

Meeting Abstract

Teo, M. Y.; Taplin, M. E.; Eastham, J. A.; Benoliel, H.; Kibel, A. S.; McBride, S. M.; Nguyen, P. L.; Gopalan, A.; Lis, R.; Scher, H. I.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Analysis of the prevalence of microsatellite instability in prostate cancer and response to immune checkpoint blockade

Journal Article

Abida, W.; Cheng, M. L.; Armenia, J.; Middha, S.; Autio, K. A.; Vargas, H. A.; Rathkopf, D.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; more...
JAMA Oncology (2019)

Fulltext@MSK | Save